Antibiotics for secondary prevention of coronary heart disease-Reference-Cited by-同舟云学术

Antibiotics for secondary prevention of coronary heart disease

Published:2021-02-23 Issue:5 Volume:2021 Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Sethi Naqash J¹,Safi Sanam¹,Korang Steven Kwasi¹,Hróbjartsson Asbjørn²³,Skoog Maria¹⁴,Gluud Christian¹⁵⁶,Jakobsen Janus C¹⁵⁶

Affiliation:

1. Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

2. Centre for Evidence-Based Medicine Odense (CEBMO) and Cochrane Denmark; Department of Clinical Research, University of Southern Denmark; Odense Denmark

3. Open Patient data Explorative Network (OPEN); Odense University Hospital; Odense Denmark

4. Clinical Study Support; Clinical Studies Sweden - Forum South; Lund Sweden

5. Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark

6. Department of Regional Health Research, The Faculty of Health Sciences; University of Southern Denmark; Odense Denmark

Publisher

Wiley

Subject

Pharmacology (medical)

Reference237 articles.

1. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease and serological evidence for Chlamydia pneumoniae infection. The Azithromycin in Coronary Artery Disease: Elimination of Myocardial Infection with Chlamydia (ACADEMIC) Study;Anderson;Circulation,1999

2. Randomized secondary prevention trial of azithromycin in patients with coronary artery disease. Primary clinical results of the ACADEMIC study;Muhlestein;Circulation,2000

3. Azithromycin for the secondary prevention of coronary events;Grayston;New England Journal of Medicine,2005

4. Description and status of the azithromycin and coronary events study (ACES);Jackson;Journal of Infectious Diseases,2000

5. Azithromycin and Coronary Events Study (ACES) https://clinicaltrials.gov/ct2/show/NCT00000617

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xinkeshu tablets promote angiogenesis in zebrafish embryos and human umbilical vein endothelial cells through multiple signaling pathways;Journal of Ethnopharmacology;2023-10

2. Effect of antibiotics as an adjuvant to subgingival instrumentation on systemic inflammation in patients with periodontitis: a randomized clinical trial;QUINTESSENCE INT;2023

3. Pericoronary adipose tissue differences among plaque types: a retrospective assessment;Clinical Imaging;2023-04

4. Diagnostic value of peripheral blood miR‐296 combined with vascular endothelial growth factor B on the degree of coronary artery stenosis in patients with coronary heart disease;Journal of Clinical Ultrasound;2023-02-28

5. Gut Microbiota and Coronary Artery Disease: Current Therapeutic Perspectives;Metabolites;2023-02-09